Cynthia Collins, CEO at Editas Medicine, Inc. (EDIT), sold 10,386 shares at $25.83 ($268K) on 2019-08-19, disclosed to the SEC on 2019-08-21.
Open-market sale of $268k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.83 | 5,193 | $134K | 50.0% |
| 2 | $25.83 | 5,193 | $134K | 50.0% |
| Total | $25.83 avg | 10,386 | $268K | 100% |
| Filing → |
| BEC | SELL | 2009-01-06 | $9K | — | Filing → |